Support For Infrastructure of Childhood Leukemia Environmental Research
支持儿童白血病环境研究基础设施
基本信息
- 批准号:10588560
- 负责人:
- 金额:$ 38.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcute Lymphocytic LeukemiaAcute Myelocytic LeukemiaAddressAffectAsianAwarenessBirth WeightBreast FeedingCaliforniaCase/Control StudiesChemical ExposureChemicalsChildChildhoodChildhood LeukemiaCollaborationsCommunitiesCosta RicaCosta RicanCountryDataData SourcesDatabasesDeveloped CountriesDevelopmentDietDiseaseDisparityEducationEducation and OutreachEducational workshopEnrollmentEnvironmentEnvironmental EpidemiologyEnvironmental HealthEnvironmental Risk FactorEquipment and supply inventoriesEthnic PopulationEtiologyExposure toFAIR principlesFundingGeneticGoalsGuatemalaHealthHealth ProfessionalHispanicImmuneImmune responseIncidenceIndividualInfrastructureInstitutionInternationalInvestigationLatin AmericaLatin AmericanLatinxLatinx populationLinkMaintenanceMalignant Childhood NeoplasmMalignant NeoplasmsMexicanMexicoMultimediaMyelogenousNational Institute of Environmental Health SciencesNeighborhoodsOutcomeOutcome StudyPopulationPopulation HeterogeneityPopulation StudyPreventionProceduresPrognosisPublic HealthPublicationsR24Recording of previous eventsResearchResearch PersonnelResource SharingResourcesRiskRisk FactorsRoleSeminalSocioeconomic StatusSourceSurvivorsSystemTranslational ResearchTumor BiologyUnited StatesVitaminsVulnerable Populationsbilingualismbuilt environmentcarcinogenicitycase controlcommunity engagementdata archivedata sharingdata sharing networksdesigndietarydisorder riskelectronic bookepidemiology studyethnic diversitygenetic risk factorhealth organizationimprovedinteroperabilityleukemiamedical specialtiesoutreachprenatalprocess improvementpublic databaseracial populationsocialsocial factorsstressorsurvivorshiptrendwebinar
项目摘要
ABSTRACT
Leukemia is the most common pediatric cancer affecting more than 40,000 children worldwide each year. During
the last decades, childhood leukemia incidence has increased in the US by ~35% overall, with an even larger
rise among LatinX. Similar trends are also observed in several Latin American countries. This rapid increase
points to the critical role of environmental factors in the development childhood leukemia, possibly in combination
with genetic factors. Despite improved prognosis of childhood leukemia overall, there are major differences by
subtype, region, racial/ethnic group, and socio-economic status, and leukemia survivors remain at risk for serious
lifelong complications. Altogether, these observations highlight the need to support more research and
prevention to reduce leukemia burden and disparity. The overall objective of this U24 competing renewal is to
expand the support of existing population studies (here case-control design) to accelerate childhood leukemia
environmental research and prevention, with a focus on LatinX populations. In the first R24 cycle (2017-22), we
maintained and enhanced the resources and data sharing of two NIEHS-funded studies with large numbers of
LatinX children in California, United States and Guatemala. To further address childhood leukemia disparity in
LatinX, while increasing diversity of the research team, we now propose to (i) include additional childhood
leukemia studies with low-resources in Mexico and Costa Rica, (ii) coordinate research translation/prevention
among participating countries, and (iii) collaborate with LatinX researchers and health workers in California and
Latin America. The four participating studies have enrolled 8,480 childhood leukemia cases and 4,462 controls,
and have collected a wealth of environmental/genetic data and biospecimens providing the most comprehensive
resources in LatinX populations worldwide. Individually or as part of the Childhood Cancer and Leukemia
Consortium (CLIC), these studies have produced seminal findings, documenting the prenatal origin of childhood
leukemia and identifying many factors that contribute to the increased or decreased risks of the disease including
chemical exposures, diet/vitamins, breastfeeding, immune response, birthweight and genetic factors. The
maintenance of these resources and the enhancement of data sharing procedures are needed to efficiently
expand ongoing etiologic and tumor-biology studies of childhood leukemia, especially myeloid subtypes which
are more common in LatinX, and uncover sources of disparity in leukemia risk and outcomes. To achieve our
goals, we plan to (1) use an interoperable management system REDCap to provide unifying support for
management, harmonization, storage and sharing of study resources; (2) enrich case-control studies by
conducting linkages to population-level databases on exposures to potential carcinogenic agents/mixtures and
social/built environments; (3) facilitate broader data use nationally and internationally with the CLIC Consortium,
and (4) expand community engagement with the public, lay health workers, and health professionals in the US
and Latin American countries to increase awareness about preventable risk factors of childhood leukemia.
抽象的
白血病是最常见的儿科癌症,每年影响全球40,000多名儿童。期间
在过去的几十年中,美国的童年白血病的发病率增加了约35%,甚至更大
在拉丁裔之间上升。在几个拉丁美洲国家也观察到类似的趋势。这种快速增加
指出环境因素在开发儿童白血病中的关键作用,可能是结合
与遗传因素。尽管总体上对儿童白血病的预后有所改善,但仍有主要差异
亚型,地区,种族/族裔和社会经济地位和白血病幸存者仍处于严重严重的危险中
终身并发症。这些观察总共凸显了支持更多研究和
预防减轻白血病负担和差异。该U24竞争续约的总体目标是
扩大现有人群研究的支持(此处病例对照设计),以加速儿童白血病
环境研究和预防,重点是拉丁人。在第一个R24周期(2017-22)中,我们
维护并增强了两项NIEHS资助研究的资源和数据共享
加利福尼亚,美国和危地马拉的拉丁裔儿童。进一步解决儿童白血病差异
Latinx在增加研究团队的多样性的同时,我们现在建议(i)包括额外的童年
白血病研究在墨西哥和哥斯达黎加,(ii)协调研究翻译/预防
在参与国家中,(iii)与加利福尼亚州的拉丁裔研究人员和卫生工作者合作
拉美。这四项参与研究已经招募了8,480个儿童白血病病例和4,462例对照,
并收集了大量的环境/遗传数据和生物测量,提供了最全面的
全球拉丁人种群的资源。单独或作为儿童期癌症和白血病的一部分
财团(CLIC),这些研究产生了开创性发现,记录了儿童期的产前。
白血病并确定许多导致疾病风险增加或降低的因素
化学暴露,饮食/维生素,母乳喂养,免疫反应,出生体重和遗传因素。这
维护这些资源并需要增强数据共享程序以有效
扩大儿童白血病的持续病因学和肿瘤生物学研究,尤其是髓样亚型
在拉丁裔中更常见,并且发现白血病风险和结果的差异来源。实现我们的
目标,我们计划(1)使用可互操作的管理系统REDCAP来为
研究资源的管理,协调,存储和共享; (2)通过
将有关潜在致癌剂/混合物的暴露与人口级数据库进行联系
社会/建筑环境; (3)与CLIC财团在国内和国际上促进更广泛的数据使用,
(4)扩大社区与公众,外行卫生工作者和美国卫生专业人员的参与
和拉丁美洲国家,以提高人们对儿童白血病的可预防危险因素的认识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Metayer其他文献
Catherine Metayer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Metayer', 18)}}的其他基金
Exposure to per- and polyfluoroalkyl substances (PFAS) and risk of cancer in children
接触全氟烷基物质和多氟烷基物质 (PFAS) 与儿童患癌症的风险
- 批准号:
10678857 - 财政年份:2021
- 资助金额:
$ 38.61万 - 项目类别:
Fetal Origins of Testicular Cancer: A Metabolomics Study in Newborns
睾丸癌的胎儿起源:新生儿代谢组学研究
- 批准号:
10426083 - 财政年份:2021
- 资助金额:
$ 38.61万 - 项目类别:
Exposure to per- and polyfluoroalkyl substances (PFAS) and risk of cancer in children
接触全氟烷基物质和多氟烷基物质 (PFAS) 与儿童患癌症的风险
- 批准号:
10310918 - 财政年份:2021
- 资助金额:
$ 38.61万 - 项目类别:
Support for Infrastructure of Childhood Leukemia Environmental Research
支持儿童白血病环境研究基础设施
- 批准号:
10172904 - 财政年份:2017
- 资助金额:
$ 38.61万 - 项目类别:
Support for Infrastructure of Childhood Leukemia Environmental Research
支持儿童白血病环境研究基础设施
- 批准号:
9385454 - 财政年份:2017
- 资助金额:
$ 38.61万 - 项目类别:
Childhood Leukemia International Consortium Scientific Annual Meetings
儿童白血病国际联盟科学年会
- 批准号:
9131744 - 财政年份:2015
- 资助金额:
$ 38.61万 - 项目类别:
Childhood Leukemia International Consortium Scientific Annual Meetings
儿童白血病国际联盟科学年会
- 批准号:
9052516 - 财政年份:2015
- 资助金额:
$ 38.61万 - 项目类别:
Childhood Leukemia International Consortium Scientific Annual Meetings
儿童白血病国际联盟科学年会
- 批准号:
9418611 - 财政年份:2015
- 资助金额:
$ 38.61万 - 项目类别:
Perinatal hormonal biomarkers and risk of testicular germ cell tumors
围产期激素生物标志物和睾丸生殖细胞肿瘤的风险
- 批准号:
8926913 - 财政年份:2014
- 资助金额:
$ 38.61万 - 项目类别:
2014 Childhood Leukemia International Consortium Annual Scientific Meeting
2014年儿童白血病国际联盟科学年会
- 批准号:
8783942 - 财政年份:2014
- 资助金额:
$ 38.61万 - 项目类别:
相似国自然基金
RBMX通过m6A依赖性相分离调控急性T淋巴细胞白血病发生发展的作用及机制研究
- 批准号:82300189
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
解析急性淋巴细胞白血病染色质可及性异常导致其糖皮质激素耐药的底层分子机制
- 批准号:82270155
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
基因工程敲减IL-6/CD40L的CAR-T细胞在复发/难治性急性B淋巴细胞白血病治疗中提高安全性的机制研究
- 批准号:82200249
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
解析急性淋巴细胞白血病染色质可及性异常导致其糖皮质激素耐药的底层分子机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基因工程敲减IL-6/CD40L的CAR-T细胞在复发/难治性急性B淋巴细胞白血病治疗中提高安全性的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
- 批准号:
10655162 - 财政年份:2023
- 资助金额:
$ 38.61万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 38.61万 - 项目类别:
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML
用于儿科 AML 可测量残留疾病监测的个性化分子检测的临床前验证
- 批准号:
10643568 - 财政年份:2023
- 资助金额:
$ 38.61万 - 项目类别:
Clonal analysis of cancer by mitochondrial DNA barcoding
通过线粒体 DNA 条形码对癌症进行克隆分析
- 批准号:
10612155 - 财政年份:2023
- 资助金额:
$ 38.61万 - 项目类别: